Skip to content

Search

Showing results for "A"

Philanthropic legacy dedicated to seeing all kids with cancer survive and thrive

One of WA’s biggest ever philanthropic gifts will transform childhood cancer research and treatment by improving outcomes for children with cancer and discovering more effective and less toxic treatments.

New eczema storybook to promote healthy skin

A children’s book – written by community, for community – has been launched in Western Australia’s south-west to help children and families understand more about one of the most common inflammatory skin conditions in children. 

The Three C’s that can help keep your kids safe online

The Kids Research Institute Australia cyber safety expert Professor Donna Cross says parents should use the ‘three C’s’ to help keep their children safe online.

WA first international hub for Human Vaccines Project

Thanks to a partnership with Perth Children’s Hospital Foundation, Perth’s The Kids Research Institute Australia will be at the forefront of a global push to decode the human immune system to transform how we prevent, diagnose and treat disease as the first international hub of the Human Vaccines Project.

Major funding aims to improve skin cancer outcomes for young Aboriginal people

Vital research promoting sun smart choices and skin cancer prevention for young Aboriginal people is now underway at The Kids Research Institute Australia thanks to a $100,000 Perpetual 2024 IMPACT Philanthropy grant.

Triage phone service

Did you know that we now have a 'triage' section on the DiabHQ app with useful documents and a FAQs page.

Researcher to run 30 marathons in 30 days for kids with brain cancer

On Monday 1 September, childhood cancer researcher Jacob Byrne is lacing up his running shoes and taking the first steps of an extraordinary challenge: 30 marathons in 30 days across Perth.

The challenges of developing and optimising an assay to measure 25-hydroxyvitamin D in saliva

We have developed an LC-MS/MS assay that accurately measures saliva 25(OH)D3 levels, which correlated with serum levels

Off-target effects of bacillus Calmette-Guerin vaccination on immune responses to SARS-CoV-2: implications for protection against severe COVID-19

Because of its beneficial off-target effects against non-mycobacterial infectious diseases, bacillus Calmette-Guérin vaccination might be an accessible early intervention to boost protection against novel pathogens. Multiple epidemiological studies and randomised controlled trials are investigating the protective effect of BCG against coronavirus disease 2019 (COVID-19).